MedPath

Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation

Phase 3
Recruiting
Conditions
Disseminated Intravascular Coagulation
Sepsis
Interventions
Registration Number
NCT02654561
Lead Sponsor
China Medical University, China
Brief Summary

The primary objective of this study is to estimate the efficacy of unfractionated heparin(UFH) on ICU mortality in severe sepsis with suspected DIC.The Second objective is to estimate the effect of UFH on 28-day mortality,and the change of the Japanese Association for Acute Medicine(JAAM) score and SOFA score. The third one is to evaluate the safety of UFH in severe sepsis patients with suspected DIC.

Detailed Description

During the study, the whole process of data validation and registry procedures will be implemented by the Principal Investigator of the study, and monitored by the Ethics Committee of the First Affiliated Hospital of China Medical University.There are 2 research supervisors(2 ICU doctors) to assess the accuracy, completeness and representativeness of registry data, and to report the study process and research results to Principal Investigator.Investigators have also edited a data dictionary including each variable used by the registry and normal ranges of all detection indexes. The standard operating procedures have been formulated to address the registry and data analysis. The feasibility and significance have been assessed carefully and funded by the Health and Family Planning Commission of Liaoning Province(No.LNCC-B01-2014).The sample size is 600 participants through statistic calculation. The plan for missing data and statistical analysis will be implemented by specialized statisticians of China Medical University.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Clinical diagnosis of severe sepsis or/and septic shock
  • suspected DIC:the score of Platelets plus International Normalized Ratio in the JAAM criteria is equal or more than 3 scores
Exclusion Criteria
  • consent declined
  • pregnant or breastfeeding
  • the length during ICU is less than 24 hours
  • with other types of shock
  • have bleeding or high risk for bleeding
  • have an indication for therapeutic anticoagulation
  • have a known or suspected adverse reaction to UFH including HIT
  • are currently enrolled in another trial
  • known or suspected cirrhosis or other severe hepatic diseases
  • terminal illness with a life expectancy of less than 28 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HeparinSalineIf severe sepsis with suspected DIC is diagnosed, the Heparin sodium(2ml:12500 units) will be administered intravenously continuously for 24 hours. The course of treatment will last 7 days or until the death or discharge.
SalineSaline-
HeparinHeparin SodiumIf severe sepsis with suspected DIC is diagnosed, the Heparin sodium(2ml:12500 units) will be administered intravenously continuously for 24 hours. The course of treatment will last 7 days or until the death or discharge.
Primary Outcome Measures
NameTimeMethod
ICU mortalityduring ICU stay (up to day 28)

The mortality during ICU stay

Secondary Outcome Measures
NameTimeMethod
28-day all-cause mortalityafter 28 days of enrollment of all the cases

The all-cause mortality at day 28 after enrollment

the incidence of major bleedingduring ICU stay (up to day 28)

"Major bleeding" is defined as intracranial bleeding, life-threatening bleeding, or need red blood cell suspension more than 3 units every 24 hours,and last for 2 days

Trial Locations

Locations (17)

The fist Affiliated Hospital Harbin Medical University

🇨🇳

Haerbin, Heilongjiang, China

Xiangya Third Hospital of Central South University

🇨🇳

Changsha, Hunan, China

First Affiliated Hospital of Dalian Medical University

🇨🇳

Dalian, Liaoning, China

Zhongda Hospital

🇨🇳

Nanjing, Jiangsu, China

Second Affiliated Hospital of Dalian Medical University

🇨🇳

Dalian, Liaoning, China

West China Hospital of Sichuan University

🇨🇳

Chengdu, Sichuan, China

Qilu Hospital of Shandong University(qingdao)

🇨🇳

Qingdao, Shandong, China

Changgeng Hospital of Tsinghua University

🇨🇳

Beijing, China

Shenyang Fourth People's Hospital

🇨🇳

Shenyang, Liaoning, China

First Affiliated Hospital of Kunming Medical University

🇨🇳

Kunming, Yunnan, China

second Affiliated Hospital of china Medical University

🇨🇳

Shenyang, Liaoning, China

the Second Affiliated Hospital of Kunming University

🇨🇳

Kunming, Yunnan, China

People's Hospital of Peking University

🇨🇳

Beijing, China

Beijing Friendship Hospital , Capital Medical University

🇨🇳

Beijing, China

First Affiliated Hospital of Jilin Medical University

🇨🇳

Jilin, China

Qinhuangdao First Hospital

🇨🇳

Qinhuangdao, China

Liaoning Provincial People's Hospital

🇨🇳

Shenyang, China

© Copyright 2025. All Rights Reserved by MedPath